Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China
· Delayed Price · Currency is CNY 13.05
+0.04 (0.31%)
At close: Apr 30, 2025, 2:57 PM CST
SHE:301246 Revenue
Hubei Hongyuan Pharmaceutical Technology had revenue of 433.46M CNY in the quarter ending March 31, 2025, with 1.73% growth. This brings the company's revenue in the last twelve months to 1.78B, down -10.06% year-over-year. In the year 2024, Hubei Hongyuan Pharmaceutical Technology had annual revenue of 1.77B, down -13.83%.
Revenue (ttm)
1.78B
Revenue Growth
-10.06%
P/S Ratio
2.92
Revenue / Employee
856.92K
Employees
2,075
Market Cap
5.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.77B | -284.16M | -13.83% |
| Dec 31, 2023 | 2.05B | -8.84M | -0.43% |
| Jan 1, 2023 | 2.06B | 485.86M | 30.79% |
| Jan 1, 2022 | 1.58B | 274.92M | 21.10% |
| Jan 1, 2021 | 1.30B | -271.47M | -17.24% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |